Emcure Pharma’s IPO will hit the market on July 03, 2024, and close on July 05, 2024. The Emcure Pharma IPO GMP Kostak rate and subject to sauda updated as of today. The Emcure Pharma IPO Grey Market Premium has started with high premium rates at this time, we need to wait for the rates to change with the market sentiment in a few days or to stabilize the rates. You can check Emcure Pharma’s IPO subscription status here.
Emcure Pharmaceuticals is a leading Indian pharmaceutical company engaged in developing, manufacturing, and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. The company is a research and development (“R&D”) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled us to reach a range of target markets across over 70 countries, with a strong presence in India, Europe, and Canada.
Emcure Pharma IPO Issue size of ₹1152.03 Crores, in which Fresh Issue of ₹800.00 Crores and Offer For Sale of ₹1152.03 Crores and issue price band has been fixed at ₹960 to ₹1008 Per Share. The Emcure Pharma IPO is to be listed on July 10, 2024, on NSE and BSE.
What is Emcure Pharma IPO GMP Today?
■ The Emcure Pharma IPO GMP Today Or Grey Market Premium is ₹330.
What is Emcure Pharma IPO Kostak Rates Today?
■ The Emcure Pharma IPO Kostak rate is ₹0.
What is Emcure Pharma IPO Subject to Sauda Price Today?
■ The Emcure Pharma IPO Subject to Sauda rates is ₹3500.
Emcure Pharma IPO Approximately Returns?
■ The Emcure Pharma IPO’s approximate return is 32%, and it can also change according to the Market Sentiment.
Emcure Pharma IPO GMP Live, Kostak, & Subject :
| Date | GMP | Kostak | Subject |
| 04 Jul 2024 | ₹330  | ₹0 | ₹3500 |
| 03 Jul 2024 | ₹330  | ₹0 | ₹3500 |
| 02 Jul 2024 | ₹300 | ₹0 | ₹3200 |
| 01 Jul 2024 | ₹285 | ₹0 | ₹3000 |
| 30 Jun 2024 | ₹264 | ₹0 | ₹2800 |
| 29 Jun 2024 | ₹264  | ₹0 | ₹2800 |
| 28 Jun 2024 | ₹270 | ₹0 | ₹2800 |
| 27 Jun 2024 | ₹0 | ₹0 | ₹0 |
IPO GMP Facts :
- The GMP is usually higher for IPOs of well-known companies with strong fundamentals.
- The GMP is also likely to be higher for IPOs that are heavily subscribed.
- It is important to do your own research before investing in an IPO, regardless of the GMP.
- The IPO GMP is estimated, considering market volatility, limited historical data, underwriting conditions, legal risks, and potential dilution.
IPO GMP Disclaimer :
- GMP is not an indicator of the final listing price: The GMP is just a reflection of the demand and supply of the IPO shares in the grey market. The final listing price will depend on a number of factors, including the overall market sentiment and the performance of the company in the post-IPO period.
- The GMP can be volatile: The GMP can fluctuate significantly in the days leading up to the IPO listing. This is due to the uncertainty surrounding the final listing price and the volatility of the stock market in general.
- There is no guarantee of profit: Even if the GMP is high, there is no guarantee that the IPO shares will list at a profit. The final listing price could be lower than the GMP, or the shares could even decline in value after listing.
- Investing in IPOs carries risks: IPOs are considered to be high-risk investments. There is always the possibility that the company could fail, or that the shares could be diluted in the future.
- Risk Factors: Identify and articulate the key risk factors that could impact the IPO GMP and subsequent trading of the company’s shares. These may include industry-specific risks, regulatory uncertainties, economic downturns, and competitive pressures.
| Emcure Pharma IPO Details: Click Here Emcure Pharma IPO Subscription: Click Here Emcure Pharma IPO Allotment: Click Here Emcure Pharma IPO Listing: Click Here |
All Emcure Pharma IPO-related links are available here. If you want to know the details then click on the click here Link.
Disclaimer: STOCK MARKET INVESTMENTS ARE SUBJECT TO MARKET RISKS, READ ALL SCHEME-RELATED DOCUMENTS CAREFULLY BEFORE INVESTING.